Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP831856.RAtg9tFt3FvxbIce7gM6Zu0WbKiyjAg9bxh3BIn2BpkHY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP831856.RAtg9tFt3FvxbIce7gM6Zu0WbKiyjAg9bxh3BIn2BpkHY130_assertion type Assertion NP831856.RAtg9tFt3FvxbIce7gM6Zu0WbKiyjAg9bxh3BIn2BpkHY130_head.
- NP831856.RAtg9tFt3FvxbIce7gM6Zu0WbKiyjAg9bxh3BIn2BpkHY130_assertion description "[To explore the characteristics of BCR-ABL kinase domain point mutations in Chinese chronic myeloid leukemia (CML) patients, a cohort of 127 patients with hematologic or cytogenetic resistance to imatinib are screened by direct sequencing.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP831856.RAtg9tFt3FvxbIce7gM6Zu0WbKiyjAg9bxh3BIn2BpkHY130_provenance.
- NP831856.RAtg9tFt3FvxbIce7gM6Zu0WbKiyjAg9bxh3BIn2BpkHY130_assertion evidence source_evidence_literature NP831856.RAtg9tFt3FvxbIce7gM6Zu0WbKiyjAg9bxh3BIn2BpkHY130_provenance.
- NP831856.RAtg9tFt3FvxbIce7gM6Zu0WbKiyjAg9bxh3BIn2BpkHY130_assertion SIO_000772 20697894 NP831856.RAtg9tFt3FvxbIce7gM6Zu0WbKiyjAg9bxh3BIn2BpkHY130_provenance.
- NP831856.RAtg9tFt3FvxbIce7gM6Zu0WbKiyjAg9bxh3BIn2BpkHY130_assertion wasDerivedFrom befree-2016 NP831856.RAtg9tFt3FvxbIce7gM6Zu0WbKiyjAg9bxh3BIn2BpkHY130_provenance.
- NP831856.RAtg9tFt3FvxbIce7gM6Zu0WbKiyjAg9bxh3BIn2BpkHY130_assertion wasGeneratedBy ECO_0000203 NP831856.RAtg9tFt3FvxbIce7gM6Zu0WbKiyjAg9bxh3BIn2BpkHY130_provenance.